Germany· DE-A57-bb8d62fb68b7ee0f
Anbinex
A medicinal product containing antithrombin iii human, registered in Germany by Grifols Deutschland Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Antithrombin Iii Human
- Manufacturer
- Grifols Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Antithrombin iii human in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANBINEXInstituto Grifols, S.A., Barcelona
- PolandAnbinexInstituto Grifols S.A.
- SpainANBINEX POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONInstituto Grifols S.A.
- NorwayAtenativOctapharma AB
- BelgiumAtenativ 1000 IUOctapharma Benelux
- SwitzerlandAtenativ 1000 I.E., Pulver und Lösungsmittel zur Herstellung einer InfusionslösungOctapharma AG
- SwedenAntithrombin III Baxalta Pulver och vätska till injektions-/infusionsvätska, lösningBaxalta Innovations GmbH
- United KingdomAntithrombin III 1,000unit powder and solvent for solution for infusion vialsImported (Austria)
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Antithrombin Iii Takeda, Atenativ
- Belgium · Antithrombin Iii Konzentrat Baxalta, Antitrombine Iii-Concentraat Baxalta
- Bulgaria · Антитромбин Iii Nf Получен От Човешка Плазма Баксалта, Атенатив
- Czechia · Anbinex, Antithrombin Iii Baxalta
- Denmark · Antitrombin Iii Baxalta, Atenativ
- Estonia · Atenativ
- Spain · Anbinex, Kybernin P
- Finland · Atenativ
- France · Aclotine, Atenativ
- Greece · Kybernin P
- Croatia · Antithrombin Iii Baxalta, Atenativ
- Hungary · Antithrombin Iii Baxalta, Atenativ
- Italy · Anbinex, Anternaty
- Lithuania · Atenativ
- Luxembourg · Kybernin P
- Latvia · Atenativ
- Malta · Antithrombin Iii Baxalta
- Netherlands · Antitrombine Iii Concentraat Baxalta, Atenativ
- Norway · Atenativ
- Poland · Anbinex, Antithrombin Iii Nf Takeda
- Portugal · Anbinex, Atenativ
- Romania · Atenativ
- Sweden · Antithrombin Iii Baxalta, Antithrombin Iii Octapharma
- Slovenia · Atenativ, Kybernin P
- Slovakia · Anbinex, Antithrombin Iii Ľudský Antitrombín Iii Získaný Z Plazmy Baxalta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf29b35c-1f13-4700-9c1d-0114005f8742 GET /v1/drugs/bf29b35c-1f13-4700-9c1d-0114005f8742?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Antithrombin Iii Human",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about antithrombin iii human.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.